These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Experience with adjuvant chemoimmunotherapy with DTIC and BCG in malignant melanoma (author's transl)]. Pullmann H; Muth M Z Hautkr; 1982 Feb; 57(4):294-7. PubMed ID: 7080583 [No Abstract] [Full Text] [Related]
10. [Malignant melanoma and its treatment]. Luther U; Dichmann S; Norgauer J Med Monatsschr Pharm; 2001 Nov; 24(11):356-61. PubMed ID: 11727297 [No Abstract] [Full Text] [Related]
11. [Possibilities of an immunotherapy of malignant skin tumors with particular consideration of malignant melanomas (author's transl)]. Schöpf E Ther Umsch; 1976 Aug; 33(8):538-42. PubMed ID: 1006610 [No Abstract] [Full Text] [Related]
12. [On the therapy of melanomalignomas. Study based on 141 follow-up determined phase I melanomas]. Storck H Schweiz Med Wochenschr; 1968 Oct; 98(40):1552-61. PubMed ID: 5701073 [No Abstract] [Full Text] [Related]
13. [Desmoplastic malignant melanoma. A case report (author's transl)]. Chasle J; Borel B; Van Hoa L; Mandard AM Arch Anat Cytol Pathol; 1979; 27(6):389-93. PubMed ID: 555279 [No Abstract] [Full Text] [Related]
15. [Melanoma and non-melanoma skin cancer]. Saida T Gan To Kagaku Ryoho; 2009 Apr; 36(4):572. PubMed ID: 19408415 [No Abstract] [Full Text] [Related]
16. Malignant melanoma: current perspectives with emphasis upon treatment according to prognosis. Polk HC J Ky Med Assoc; 1978 Dec; 76(12):593-8. PubMed ID: 722156 [No Abstract] [Full Text] [Related]